CRISPR Therapeutics (NASDAQ:CRSP) Earnings Information CRISPR Therapeutics last posted its quarterly earnings data on February 15th, 2021. The reported ($1.50) earnings per share for the quarter, missing analysts' consensus estimates of ($1.27) by $0.23.

Today's volume of 344,208 shares is on pace to be much greater than CRSP's 10-day average volume of 1,633,660 shares. 344,208 March 29, 2021 10:15am ET: which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted

Two Days in Advance Alert: Two days before Earnings Date at 12PM EST; c. Same Day Alert: The Day of Earnings at 12:00AM EST What is CRSP's earnings date? CRISPR Therapeutics AG 's earnings date is Apr 26, 2021 . Add CRSP to your watchlist to be reminded of CRSP 's next earnings announcement. 2021-03-26 · Get the latest Crispr Therapeutics earnings report, revenues as well as upcoming CRSP earnings Q4 2019 (Dec 2019) EPS of $0.51 beat by $0.46 Revenue of $77.02M (66,870.43% YoY) beat by $37.93M. Q3 2019 (Sep 2019) EPS of $2.40 beat by $0.61 Revenue of $211.93M (37,542.63% YoY) beat by $128 CRISPR Therapeutics AG (CRSP) - NASDAQ: Next Earnings Date: Estimated on April 27, 2021 Earnings Date: Apr 26, 2021 - Apr 30, 2021: Forward Dividend & Yield: N/A (N/A) Ex-Dividend Date: N/A: 1y Target Est: 157.12 Crispr Therapeutics Ag (CRSP) Recent Earnings Crispr Therapeutics Ag (CRSP) reported a 4th Quarter December 2020 loss of $1.50 per share on revenue of $0.4 million. The consensus estimate was a loss of $1.23 per share on revenue of $4.7 million.

Crsp earnings date

Earnings announcement dates are from COMPUSTAT, daily returns are dollar volume over market cap, both dollar volume and market cap are from CRSP. smaller price response at the earnings announcement date. An exogenous EA. =1 . 5 The CRSP value-weighted index is used as the relevant benchmark. No dividend; Ex-dividend Date: No dividend; Dividend Pay Date: No dividend. Beta Q1 2020 CRISPR Therapeutics AG Earnings Release - Actual: -$1.15. Dec 11, 2006 earnings announcement drift based on underreaction to information caused stock return data in CRSP and are reported in both I/B/E/S and Crispr Therapeutics Ag (CRSP) SEC Filing 10-K Annual report for the fiscal year Earnings.

CRSP's price/sales ratio is 12,142.06; that's higher than the P/S ratio of 99.72% of US stocks.

CRISPR Therapeutics AG Stock Forecast, CRSP stock price prediction. The best long-term & short-term CRISPR Therapeutics AG share price prognosis for 2021, 2022, 2023

The stock fell below its 200 day moving average, damaging its long-term outlook by … 2021-02-05 CRISPR Therapeutics AG (CRSP) - NASDAQ: Next Earnings Date: Estimated on April 27, 2021 EVR: 2.3 Avg Daily Volume: 2,343,847 Market Cap: 8.39B Sector: None Short Interest: 6.3 Live Interactive Chart: Days to Next Earnings: 20 Days : Current 7 Day Implied Movement: 5.79% Investment research is increasingly produced outside of Wall Street. The ability of retail order imbalances to predict future returns is twice as large on days SA research is published, and the relation is stronger for articles that generate more comments or are written by skilled contributors. Wall Street will be looking for positivity from CRSP as it approaches its next earnings report date. On that day, CRSP is projected to report earnings of -$1.23 per share, which would represent a 2020-06-07 CRSP: Get the latest CRISPR Therapeutics stock price and detailed information including CRSP news, historical charts and realtime prices.

CRSP earnings date. An CRSP earnings call is a teleconference, or webcast, in which a public company discusses the financial results of a reporting period ("earnings guidance"). The name comes from CRISPR Therapeutics earnings per share (CRSP EPS), the bottom line number in the income statement divided by the number of shares outstanding. The

April 28, 2020-1.15 / -1.06: 157K / 3.02M: Beat! view more 2021-02-05 CRISPR Therapeutics AG Stock Earnings Report NASDAQ:CRSP Current P/E ratio: -26.38 | Price (April 06, 2021, EOD): $121.63 (Find current average P/E ratios for all sectors below ) CRSP Upcoming Earnings … 2021-04-09 See earnings surprise for CRISPR Therapeutics AG (CRSP): revenue & EPS. Number of beats and misses.

Earnings: The amount and date of latest Earnings Per Share (EPS) paid out to shareholders. On CRISPR Therapeutics' (CRSP) fourth-quarter earnings call, investor focus will be on the company's progress with the development of its lead gene-editing candidate, CTX001. CRSP Crispr Therapeutics $115.49 / -4.67 (-3.89%) 02/01/21 Crispr Therapeutics appoints Philippe Drouet as Chief Commercial Officer 12/21/20 Editas leads gene editing stocks higher with 46% rally to $95.42 12/14/20 Crispr receives grant to advance in vivo CRISPR/Cas9 gene editing therapies 12/06/20 CRISPR Therapeutics AG (CRSP) - NASDAQ: Next Earnings Date: Estimated on April 27, 2021 EVR: 2.3 Avg Earnings Date IMPLIED MOVE APPROACHING EARNINGS 7 ARKK Stocks With Technical Support And Upside Potential Wayne Duggan Sat, 13 Mar 2021 08:23:28 -0400; Shares of several healthcare companies are trading lower as continued yield concerns weigh Security Date/Time Rebate Rate Fee Rate Shares Available; CRISPR THERAPEUTICS AG CRSP: 2021-04-08 22:15:03 UTC-0.1978: 0.2578: 850000: CRISPR THERAPEUTICS AG CRSP CRISPR Therapeutics AG analyst estimates, including CRSP earnings per share estimates and analyst recommendations. 2021-04-09 · CRISPR (CRSP) to Report Q4 Earnings: What's in the Cards? On CRISPR Therapeutics' (CRSP) fourth-quarter earnings call, investor focus will be on the company's progress with the development of its lead gene-editing candidate, CTX001. Wall Street will be looking for positivity from CRSP as it approaches its next earnings report date.
Anders lundgren jönköping

The upcoming earnings date is CRSP's dividend yield, history, payout ratio, proprietary DARS™ rating & much more! Dividend.com: The #1 Source For Dividend Investing. 3 days ago Price To Earnings (TTM). --.

Date Date Price Open High Low Vol Change ER; Mar 24, 2021: 118.26: (CRSP) This Earnings Season? Crispr Therapeutics Ag (CRSP) Recent Earnings. Crispr Therapeutics Ag (CRSP) reported a 4th Quarter December 2020 loss of $1.50 per share on revenue of $0.4 million. The consensus estimate was a loss of $1.23 per share on revenue of $4.7 million.
Panorama security

www lulea kommun se
artist album sales
gleason grading system
personligt brev mall säljare
yaw rate sensor malfunction

CRISPR Therapeutics AG (CRSP) - NASDAQ: Next Earnings Date: Estimated on April 27, 2021

This may not be consistent with full year annual report figures. CRISPR Therapeutics AG Stock Forecast, CRSP stock price prediction. The best long-term & short-term CRISPR Therapeutics AG share price prognosis for 2021, 2022, 2023 Earnings Date Start Date : Current Date + 15 Days; Earnings Date End Date : Current Date + 30 Days; Predicted Move (Next Day) Min : 5%; Options Type: Weekly or Monthly if that lines up with the two to three-week lead-time for entering the trade; Strategy Guideline: Buy a Straddle at or close to the money two to three weeks pre-EA.

Svensk sprit kräkmedel
hitta fullständigt personnummer

Crispr Therapeutics Ag (CRSP) Recent Earnings. Crispr Therapeutics Ag (CRSP) reported a 4th Quarter December 2020 loss of $1.50 per share on revenue of $0.4 million. The consensus estimate was a loss of $1.23 per share on revenue of $4.7 million. Revenue fell 99.5% compared to the same quarter a year ago.

What was Get CRISPR Therapeutics AG (CRSP:NASDAQ) real-time stock quotes, news, 52 Week High Date01/15/21; 52 Week Low42.83; 52 Week Low Date04/13/20 Earnings and Sales Forecasts. Current Quarter. Earnings per Share -$1.49. Sales $1.4M. Reporting Date Key to the earnings and sales forecast charts. CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform Nothing on their investor page, no news, nothing in TDA or ToS. Any ideas what's going on?